Michael D Boska Selected Research

N-(2-hydroxypropyl)methacrylamide

1/2010

Development of a macromolecular prodrug for the treatment of inflammatory arthritis: mechanisms involved in arthrotropism and sustained therapeutic efficacy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michael D Boska Research Topics

Disease

4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016 - 12/2006
4	Parkinson Disease (Parkinson's Disease) 01/2016 - 02/2005
3	Infections 01/2018 - 08/2013
2	Ovarian Neoplasms (Ovarian Cancer) 09/2021 - 05/2016
2	Inflammation (Inflammations) 01/2012 - 01/2010
2	Disease Progression 04/2010 - 05/2009
1	Neoplasms (Cancer) 07/2017
1	Tobacco Use Disorder (Nicotine Dependence) 01/2017
1	Communicable Diseases (Infectious Diseases) 01/2017
1	Gliosis 01/2016
1	Neoplasm Metastasis (Metastasis) 01/2016
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2016
1	Drug-Related Side Effects and Adverse Reactions 07/2014
1	HIV Infections (HIV Infection) 07/2014
1	Central Nervous System Diseases (CNS Diseases) 12/2013
1	Persistent Infection 12/2013
1	Edema (Dropsy) 08/2013
1	Brain Edema (Cerebral Edema) 08/2013
1	Hemorrhage 08/2013
1	Craniocerebral Trauma (Head Injury) 08/2013
1	Stroke (Strokes) 08/2013
1	Nervous System Diseases (Neurological Disorders) 04/2012
1	Arthritis (Polyarthritis) 01/2010
1	Rheumatoid Arthritis 01/2010
1	Neurocognitive Disorders (Clerambault Syndrome) 08/2008
1	Encephalitis (Encephalitis, Rasmussen) 08/2008
1	Mitochondrial Diseases (Mitochondrial Disease) 02/2002

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 01/2017 - 04/2012
2	Ferrosoferric Oxide (Magnetite)FDA Link 09/2021 - 05/2016
2	Gonadotropin-Releasing Hormone (GnRH)FDA Link 09/2021 - 05/2016
2	Cisplatin (Platino)FDA LinkGeneric 09/2021 - 05/2016
2	Contrast MediaIBA 07/2017 - 01/2012
2	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2016 - 02/2005
2	ManganeseIBA 01/2016 - 01/2016
1	nitroxylIBA 07/2017
1	MetalsIBA 07/2017
1	Nicotine FDA Link 01/2017
1	LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA 05/2016
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2016
1	Type II Vasoactive Intestinal Peptide ReceptorsIBA 01/2016
1	EnzymesIBA 01/2016
1	Chemokine ReceptorsIBA 01/2016
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 01/2016
1	Phosphotransferases (Kinase)IBA 01/2016
1	Choline (Choline Chloride)IBA 12/2013
1	CreatineIBA 12/2013
1	Phosphorylcholine (Phosphocholine)IBA 12/2013
1	ChemokinesIBA 08/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2013
1	Amino Acids FDA Link 04/2012
1	Inositol (Myoinositol)IBA 04/2012
1	GadoliniumIBA 01/2012
1	Matrix Metalloproteinases (MMPs)IBA 01/2010
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2010
1	N-(2-hydroxypropyl)methacrylamideIBA 01/2010
1	Interleukin-6 (Interleukin 6)IBA 01/2010
1	LipopolysaccharidesIBA 01/2010
1	ProdrugsIBA 01/2010
1	hydroxypropyl methacrylateIBA 01/2010
1	Therapeutic UsesIBA 05/2009
1	TEMPOIBA 08/2008
1	ferric oxide (iron oxide)IBA 08/2008
1	Glutamic Acid (Glutamate)FDA Link 12/2006
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2006
1	Quinolinic AcidIBA 12/2006
1	Pentoxifylline (Trental)FDA LinkGeneric 02/2002
1	Phosphorus (Red Phosphorus)IBA 02/2002

Therapy/Procedure

3	Therapeutics 01/2016 - 04/2010
2	Drug Therapy (Chemotherapy) 09/2021 - 05/2016
2	Precision Medicine 01/2017 - 05/2016
1	Laser Therapy (Surgery, Laser) 01/2018
1	Art Therapy 07/2014
1	Decompressive Craniectomy 08/2013